尋找研究成果

搜尋結果

• A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer

  Chen, L. T., Liu, T. W., Wu, C. W., Chung, T. R., Shiah, H. S., Jan, C. M., Ming Liu, J., Whang-Peng, J. & Chang, J. Y., 12月 1 2002, 於: Oncology. 63, 3, p. 239-247 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  17 引文 斯高帕斯（Scopus）

• A phase i study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors

  Mortazavi, A., Ling, Y., Martin, L. K., Wei, L., Phelps, M. A., Liu, Z., Harper, E. J., Ivy, S. P., Wu, X., Zhou, B. S., Liu, X., Deam, D., Monk, J. P., Hicks, W. J., Yen, Y., Otterson, G. A., Grever, M. R. & Bekaii-Saab, T., 6月 1 2013, 於: Investigational New Drugs. 31, 3, p. 685-695 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  25 引文 斯高帕斯（Scopus）

• A phase I study of oxaliplatin in combination with gemcitabine: Correlation of clinical outcome with gene expression

  Shibata, S., Chow, W., Frankel, P., Juhasz, A., Leong, L., Lim, D., Margolin, K., Morgan, R., Newman, E., Somlo, G., Yen, Y., Synold, T., Gandara, D., Lenz, H. J. & Doroshow, J., 3月 1 2007, 於: Cancer Chemotherapy and Pharmacology. 59, 4, p. 549-557 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  4 引文 斯高帕斯（Scopus）

• A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A

  Raschko, J. W., Synold, T. W., Chow, W., Coluzzi, P., Hamasaki, V., Leong, L. A., Margolin, K. A., Morgan, R. J., Shibata, S. I., Somlo, G., Tetef, M. L., Yen, Y., Ter Veer, A. & Doroshow, J. H., 2000, 於: Cancer Chemotherapy and Pharmacology. 46, 5, p. 403-410 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  7 引文 斯高帕斯（Scopus）

• A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline

  Hong, R. L., Lin, C. H., Chao, T. Y., Kao, W. Y., Wang, C. H., Hsieh, R. K. & Hwang, W. S., 4月 2008, 於: Cancer Chemotherapy and Pharmacology. 61, 5, p. 847-853 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  9 引文 斯高帕斯（Scopus）

• A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study

  Kirschbaum, M. H., Frankel, P., Synold, T. W., Xie, Z., Yen, Y., Popplewell, L., Chen, R., Aljitawi, O., Tuscano, J. M., Chan, K. K. & Newman, E. M., 10月 2 2016, 於: Leukemia and Lymphoma. 57, 10, p. 2307-2314 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  4 引文 斯高帕斯（Scopus）

• A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older

  Chen, Y. M., Perng, R. P., Chen, M. C., Tsai, C. M., Ming-Liu, J. & Whang-Peng, J., 5月 1 2003, 於: Lung Cancer. 40, 2, p. 221-226 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  23 引文 斯高帕斯（Scopus）

• A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer

  Perng, R. P., Shih, J. F., Chen, Y. M., Delgado, F. M., Tsai, C. M., Chou, K. C., Liu, J. M., Chern, M. S. & Whang-Peng, J., 2月 1 2000, 於: American Journal of Clinical Oncology: Cancer Clinical Trials. 23, 1, p. 60-64 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  11 引文 斯高帕斯（Scopus）

• A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer

  Chen, Y. M., Perng, R. P., Yang, K. Y., Lin, W. C., Wu, H. W., Liu, J. M., Tsai, C. M. & Whang-Peng, J., 2月 1 2000, 於: American Journal of Clinical Oncology: Cancer Clinical Trials. 23, 1, p. 13-17 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  15 引文 斯高帕斯（Scopus）

• A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy

  Chen, Y. M., Perng, R. P., Tsai, C. M. & Whang-Peng, J., 6月 1 2006, 於: Lung Cancer. 52, 3, p. 333-338 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  7 引文 斯高帕斯（Scopus）

• A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma

  Chen, J. S., Chao, Y., Yang, T. S., Chou, W. C., Chen, L. T., Lee, K. D. & Lin, Y. C., 2009, 於: Cancer Chemotherapy and Pharmacology. 65, 1, p. 151-157 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  5 引文 斯高帕斯（Scopus）

• A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck

  Wang, T. F., Chu, S. C., Kao, R. H., Yao, C. Y. & Li, C. C., 8月 12 2008, 於: Japanese Journal of Clinical Oncology. 38, 7, p. 459-463 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  3 引文 斯高帕斯（Scopus）

• A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

  Li, C. P., Chen, J. S., Chen, L. T., Yen, C. J., Lee, K. D., Su, W. P., Lin, P. C., Lu, C. H., Tsai, H. J. & Chao, Y., 10月 26 2010, 於: British Journal of Cancer. 103, 9, p. 1343-1348 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  14 引文 斯高帕斯（Scopus）

• A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer

  Sridhar, S. S., Canil, C. M., Chi, K. N., Hotte, S. J., Ernst, S., Wang, L., Chen, E. X., Juhasz, A., Yen, Y., Murray, P., Zwiebel, J. A. & Moore, M. J., 4月 1 2011, 於: Cancer Chemotherapy and Pharmacology. 67, 4, p. 927-933 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  22 引文 斯高帕斯（Scopus）

• A phase II study of S-1 plus oral leucovorin in heavily treated metastatic colorectal cancer patients

  Hsu, H. C., Chou, W. C., Kuan, F. C., Lee, K. D., Rau, K. M., Huang, J. S. & Yang, T. S., 1月 1 2018, 於: Cancer Management and Research. 10, p. 6061-6070 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  3 引文 斯高帕斯（Scopus）

• A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

  Ramanathan, R. K., Belani, C. P., Singh, D. A., Tanaka, M., Lenz, H. J., Yen, Y., Kindler, H. L., Iqbal, S., Longmate, J., MacK, P. C., Lurje, G., Gandour-Edwards, R., Dancey, J. & Gandara, D. R., 9月 1 2009, 於: Cancer Chemotherapy and Pharmacology. 64, 4, p. 777-783 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  238 引文 斯高帕斯（Scopus）

• A phase II study of hydroxyurea combined with gemcitabine in patients with head and neck squamous carcinoma and gene expression profiles correlated to poor response

  Zhang, K., Kim, C., Wu, X., Loera, S., Wang, Y., Chu, P., Lim, D., Shibata, S. & Yen, Y., 2月 27 2013, 於: Head and Neck Oncology. 5, 3, 3.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

  Ciuleanu, T., Tsai, C. M., Tsao, C. J., Milanowski, J., Amoroso, D., Heo, D. S., Groen, H. J. M., Szczesna, A., Chung, C. Y., Chao, T. Y., Middleton, G., Zeaiter, A., Klingelschmitt, G., Klughammer, B. & Thatcher, N., 11月 2013, 於: Lung Cancer. 82, 2, p. 276-281 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  32 引文 斯高帕斯（Scopus）

• A phase ii study of carboplatin in nasopharyngeal carcinoma

  Chi, K. H., Chang, Y. C., Chan, W. K., Liu, J. M., Law, C. K., Lo, S. S., Shu, C. H., Yen, S. H., Whang-Peng, J. & Chen, K. Y., 1月 1 1997, 於: Oncology (Switzerland). 54, 3, p. 203-207 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  12 引文 斯高帕斯（Scopus）

• A phase II randomized trial of gefitinib alone or with Tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy

  Chen, Y. M., Fan, W. C., Tsai, C. M., Liu, S. H., Shih, J. F., Chou, T. Y., Wu, C. H., Chou, K. T., Lee, Y. C., Perng, R. P. & Whang-Peng, J., 6月 2011, 於: Journal of Thoracic Oncology. 6, 6, p. 1110-1116 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  24 引文 斯高帕斯（Scopus）

• A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly

  Chen, Y. M., Perng, R. P., Shih, J. F. & Whang-Peng, J., 8月 2008, 於: Lung Cancer. 61, 2, p. 214-219 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  19 引文 斯高帕斯（Scopus）

• A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly

  Chen, Y. M., Perng, R. P., Tsai, C. M. & Whang-Peng, J., 2月 1 2006, 於: Journal of Thoracic Oncology. 1, 2, p. 141-145 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  25 引文 斯高帕斯（Scopus）

• A phase II double-blinded study to evaluate the efficacy of EW02 in reducing chemotherapy-induced neutropenia in breast cancer

  Wu, Y. Y., Liu, H. Y., Huang, T. C., Chen, J. H., Chang, P. Y., Ho, C. L. & Chao, T. Y., 9月 1 2015, 於: Oncology Letters. 10, 3, p. 1793-1798 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  1 引文 斯高帕斯（Scopus）

• A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma

  Changou, C. A., Shiah, H. S., Chen, L. T., Liu, S., Luh, F., Liu, S. H., Cheng, Y. C. & Yen, Y., 3月 2021, 於: Oncologist. 26, 3, p. e367-e373 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取
  11 引文 斯高帕斯（Scopus）

• A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan

  Chen, J. S., Chao, Y., Hsieh, R. K., Cheng, A. L., Chen, P. M., Chiou, T. J., Chao, T. Y., Yeh, K. H., Chen, L. T. & Whang-Peng, J., 6月 2011, 於: Cancer Chemotherapy and Pharmacology. 67, 6, p. 1281-1289 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  6 引文 斯高帕斯（Scopus）

• A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions

  Perng, R. P., Wu, M. F., Lin, S. Y., Chen, Y. M., Lin, J. Y. & Whang-Peng, J., 9月 16 1997, 於: Anti-Cancer Drugs. 8, 6, p. 565-573 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  21 引文 斯高帕斯（Scopus）

• A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

  Chiang, N. J., Chao, T. Y., Hsieh, R. K., Wang, C. H., Wang, Y. W., Yeh, C. G. & Chen, L. T., 11月 21 2016, 於: BMC Cancer. 16, 1, 907.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  29 引文 斯高帕斯（Scopus）

• A phase i clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment John T Kung

  Liu, K. J., Chao, T. Y., Chang, J. Y., Cheng, A. L., Ch'Ang, H. J., Kao, W. Y., Wu, Y. C., Yu, W. L., Chung, T. R. & Whang-Peng, J., 8月 24 2016, 於: Journal of Biomedical Science. 23, 1, 64.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  14 引文 斯高帕斯（Scopus）

• A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer

  Lu, Y. S., Lee, K. S., Chao, T. Y., Tseng, L. M., Chitapanarux, I., Chen, S. C., Liu, C. T., Sohn, J., Kim, J. H., Chang, Y. C., Yang, Y., Shotelersuk, K., Jung, K. H., Valenti, R., Slader, C., Gao, M. & Park, Y. H., 1月 15 2021, 於: Clinical Cancer Research. 27, 2, p. 408-417 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取
  15 引文 斯高帕斯（Scopus）

• A phase I and pharmacokinetic study of oral 3-aminopyridine-2- carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: A California Cancer Consortium Study

  Chao, J., Synold, T. W., Morgan, R. J., Kunos, C., Longmate, J., Lenz, H. J., Lim, D., Shibata, S., Chung, V., Stoller, R. G., Belani, C. P., Gandara, D. R., McNamara, M., Gitlitz, B. J., Lau, D. H., Ramalingam, S. S., Davies, A., Espinoza-Delgado, I., Newman, E. M. & Yen, Y., 3月 2012, 於: Cancer Chemotherapy and Pharmacology. 69, 3, p. 835-843 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  33 引文 斯高帕斯（Scopus）

• A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer

  Chen, T. W-W., Yeh, D-C., Chao, T-Y., Lin, C-H., Chow, L. W-C., Chang, D-Y., Hsieh, Y-Y., Huang, S-M., Cheng, A-L. & Lu, Y-S., 3月 1 2018, 於: Japanese Journal of Clinical Oncology. 48, 3, p. 242-247 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  4 引文 斯高帕斯（Scopus）

• A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: A study of the PMH phase II consortium

  Leighl, N. B., Laurie, S. A., Chen, X. E., Ellis, P., Shepherd, F. A., Knox, J. J., Goss, G., Burkes, R. L., Pond, G. R., Dick, C., Yen, Y., Zwiebel, J. A. & Moore, M. J., 1月 1 2009, 於: Journal of Thoracic Oncology. 4, 9, p. 1163-1169 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  16 引文 斯高帕斯（Scopus）

• A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis C

  Chen, C. Y., Chuang, W. L., Qin, A., Zhang, W. H., Zhu, L. Y., Zhang, G. Q., Chen, J. J., Lo, C. C., Zhou, X., Mao, X., Shang, J., Kuo, H. T., Xie, W., Chen, C. H., Lo, G. H., Jun, D. W., Dang, S., Tsai, C. Y., Wang, T. F., Lai, H. H., 及其他3Tseng, K. C., Huang, Y. W. & Chen, P. J., 2022, (接受/付印) 於: JGH Open.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

• A pharmacokinetic study with the high-dose anticancer agent menadione in rabbits

  Hu, O. Y. P., Wu, C. Y., Chan, W. K., Wu, F. Y. H. & Whang-Peng, J., 8月 1 1996, 於: Biopharmaceutics and Drug Disposition. 17, 6, p. 493-499 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  9 引文 斯高帕斯（Scopus）

• A pharmacokinetic and pharmacodynamic study of intravenous levosimendan in healthy Chinese volunteers and ethnic comparisons

  Chu, K. M., Hu, O. Y. P. & Liou, J. T., 1月 1 2014, 於: Acta Cardiologica Sinica. 30, 4, p. 298-307 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  6 引文 斯高帕斯（Scopus）

• A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan

  Ho, W. L., Chung, K. P., Yang, S. S., Lu, M. Y., Jou, S. T., Chang, H. H., Yang, Y. L., Lin, D. T. & Lin, K. H., 4月 2013, 於: Journal of the Formosan Medical Association. 112, 4, p. 221-229 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取
  10 引文 斯高帕斯（Scopus）

• A Pharmacist-initiated Project to Reduce Meperidine Use in Surgical Patients

  Wu, M. T., Wu, T. Y., Tai, Y-T., Chen, H. Y. & Kuo, L. N., 8月 2012, 於: Journal of Experimental and Clinical Medicine(Taiwan). 4, 4, p. 245-248 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  5 引文 斯高帕斯（Scopus）

• A Phantom Study of the Spatial Precision and Accuracy of Stereotactic Localization Using Computed Tomography Imaging with the Leksell Stereotactic System

  Tafreshi, A. R., Peng, T., Yu, C., Kramer, D. R., Gogia, A. S., Lee, M. B., Barbaro, M. F., Sebastian, R., Del Campo-Vera, R. M., Chen, K. H., Kellis, S. S. & Lee, B., 7月 2020, 於: World Neurosurgery. 139, p. e297-e307

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A personalized medication management platform (PMMP) to improve medication adherence: A randomized control trial

  Huang, C. Y., Nguyen, P. A. A., Clinciu, D. L., Hsu, C. K., Lu, J. C. R., Yang, H. C., Wu, C. C., Tsai, W. C., Chou, Y. C., Kuo, T. B. J., Chang, P. L., Jian, W. S. & Li, Y. C. J., 3月 1 2017, 於: Computer Methods and Programs in Biomedicine. 140, p. 275-281 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  13 引文 斯高帕斯（Scopus）

• A persistent level of CISD2 extends healthy lifespan and delays aging in mice

  Wu, C. Y., Chen, Y. F., Wang, C. H., Kao, C. H., Zhuang, H. W., Chen, C. C., Chen, L. K., Kirby, R., Wei, Y. H., Tsai, S. F. & Tsai, T. F., 9月 2012, 於: Human Molecular Genetics. 21, 18, p. 3956-3968 13 p., dds210.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  71 引文 斯高帕斯（Scopus）

• A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan

  Li, Y. H., Chen, J. W., Lin, T. H., Wang, Y. C., Wu, C. C., Yeh, H. I., Huang, C. C., Chang, K. C., Wu, C. K., Chen, P. W., Huang, C. W., Chen, Z. C., Chang, W. T., Huang, W. C., Wang, C. Y., Lee, M. Y., Chao, A. C., Fu, W. R., Tsai, L. K., Tang, S. C., 及其他5Chan, H. L., Yang, Y. C., Wu, Y. W., Hwang, J. J. & Lin, J. L., 3月 2020, 於: Journal of the Formosan Medical Association. 119, 3, p. 674-684 11 p.

  研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審

  開啟存取
  7 引文 斯高帕斯（Scopus）

• A Penetrating Tracheal Injury Caused by a Needlefish

  貢獻的翻譯標題: 針魚刺穿頸部氣管Yang, C-C., Huang, C-M., Lu, L-H., Choi, W. M., Tsai, S-H., Chiu, W-T. & Liu, H-C., 2004, 於: 中華民國急救加護醫學會雜誌. 15, 2, p. 70-74 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A pelvic motion driven electrical stimulator for drop-foot treatment

  Chen, S. W., Chen, S. C., Chen, C. F., Lai, J. S. & Kuo, T. S., 2009, Proceedings of the 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society: Engineering the Future of Biomedicine, EMBC 2009. p. 666-669 4 p. 5333671

  研究成果: 書貢獻/報告類型 › 會議貢獻
  6 引文 斯高帕斯（Scopus）

• Apelin regulates the electrophysiological characteristics of atrial myocytes

  Cheng, C. C., Weerateerangkul, P., Lu, Y. Y., Chen, Y. C., Lin, Y. K., Chen, S. A. & Chen, Y. J., 1月 2013, 於: European Journal of Clinical Investigation. 43, 1, p. 34-40 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  14 引文 斯高帕斯（Scopus）

• APEG-1, a novel gene preferentially expressed in aortic smooth muscle cells, is down-regulated by vascular injury

  Hsieh, C. M., Yoshizumi, M., Endege, W. O., Kho, C. J., Jain, M. K., Kashiki, S., De los Santos, R., Leet, W. S., Perrella, M. A. & Lee, M. E., 1996, 於: Journal of Biological Chemistry. 271, 29, p. 17354-17359 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  39 引文 斯高帕斯（Scopus）

• A peculiar site of leiomyosarcoma: the tongue tip-report of a case

  Yang, S. W., Chen, T-M., Tsai, C. Y. & Lin, C. Y., 5月 1 2006, 於: International Journal of Oral and Maxillofacial Surgery. 35, 5, p. 469-471 3 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  16 引文 斯高帕斯（Scopus）

• APEC-1, a novel gene preferentially expressed in aortic smooth muscle cells, is downregulated by vascular injury

  Hsieh, C. M., Yoshizumi, M., Endege, W. O., Kho, C. J., Jain, M., Hong, A. M., De Los Santos, R., Kashiki, S., Lee, W. S., Perrella, M. A. & Lee, M. E., 1996, 於: FASEB Journal. 10, 6

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• APC^cdh1 Activity in Mouse Oocytes Prevents Entry into the First Meiotic Division

  Reis, A., Chang, H. Y., Levasseur, M. & Jones, K. T., 5月 2006, 於: Nature Cell Biology. 8, 5, p. 539-540 2 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  130 引文 斯高帕斯（Scopus）

• A patient with encapsulating peritoneal sclerosis complicated with hepatic portal venous gas who survives conservative treatment

  Cheng, C. Y., Huang, P. J. & Chen, T. H., 1月 9 2015, 於: Peritoneal Dialysis International. 35, 5, p. 605-606 2 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A patient with bronchiectasis presented with progressive dyspnoea and an unresolved right lower lung infiltrate

  Lin, P. Y., Yu, C. J., Yao, M., Ku, S. C., Lee, L. N. & Yang, P. C., 10月 2008, 於: Thorax. 63, 10, p. 876+932

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取